ROIVANT SCIENCES LTD's ticker is and the CUSIP is G76279101. A total of 293 filers reported holding ROIVANT SCIENCES LTD in Q2 2024. The put-call ratio across all filers is 1.17 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $86,587,580 | +1.3% | 8,191,824 | +1.1% | 0.00% | 0.0% |
| Q1 2024 | $85,440,741 | +7.5% | 8,106,332 | +14.6% | 0.00% | 0.0% |
| Q4 2023 | $79,459,561 | +21.4% | 7,075,651 | +26.3% | 0.00% | 0.0% |
| Q3 2023 | $65,437,972 | +200.2% | 5,602,566 | +159.1% | 0.00% | +100.0% |
| Q2 2023 | $21,794,895 | +67.0% | 2,162,192 | +22.2% | 0.00% | – |
| Q1 2023 | $13,054,054 | -0.9% | 1,768,842 | +7.3% | 0.00% | – |
| Q4 2022 | $13,174,703 | +160.0% | 1,648,899 | +4.8% | 0.00% | – |
| Q3 2022 | $5,067,000 | -17.9% | 1,573,575 | +3.8% | 0.00% | – |
| Q2 2022 | $6,172,000 | -5.3% | 1,516,349 | +14.9% | 0.00% | – |
| Q1 2022 | $6,519,000 | -44.2% | 1,319,499 | +13.8% | 0.00% | – |
| Q4 2021 | $11,690,000 | – | 1,159,712 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VI Management, LLC | 1,119,489 | $12,571,861 | 98.63% |
| Patient Square Capital LP | 12,639,920 | $141,946,302 | 77.60% |
| QVT Financial LP | 112,541,536 | $1,263,841,449 | 71.60% |
| Two Seas Capital LP | 8,508,223 | $95,547,344 | 23.33% |
| Whitefort Capital Management, LP | 1,591,000 | $17,866,930 | 11.39% |
| Tyro Capital Management LLC | 1,345,981 | $15,115,367 | 10.65% |
| Tejara Capital Ltd | 2,134,895 | $23,974,871 | 10.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 73,031,667 | $820,145,620 | 7.30% |
| STEMPOINT CAPITAL LP | 2,169,116 | $24,359,173 | 6.50% |
| Anchorage Capital Group, L.L.C. | 4,832,642 | $54,270,570 | 6.46% |